Breaking News
July 22, 2018 - Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010
July 22, 2018 - QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies
July 22, 2018 - UK health communication researcher seeks solutions for disposing leftover medicine
July 22, 2018 - Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
July 22, 2018 - Mutation discovered to protect against Alzheimer’s disease in mice
July 22, 2018 - Researchers reveal how patients in urban areas develop multiple, long-term conditions
July 22, 2018 - Replacing conventional cancer treatment with complementary therapy linked to increased risk of death
July 22, 2018 - Study uncovers molecular key for delaying progression of multiple sclerosis
July 22, 2018 - Availability of athletic trainer in high school reduces injury rates in girls’ sports, shows study
July 22, 2018 - FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
July 22, 2018 - Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
July 22, 2018 - Physical activity even during exposure to air pollution can reduce risk of heart attack
July 22, 2018 - Scientists discover protein regulator of myelin production
July 22, 2018 - Sleep disturbances associated with higher dementia risk
July 22, 2018 - Scientists move one step further in developing eye drops to treat age-related macular degeneration
July 22, 2018 - Five-Year Stroke Rates Lower After PCI Versus CABG
July 21, 2018 - Alopecia areata – Genetics Home Reference
July 21, 2018 - Study identifies overdose risk factors in youth with substance use disorders
July 21, 2018 - Drug in clinical trials for Parkinson’s disease offers hope for treating heart failure
July 21, 2018 - Coupling free malaria tests with diagnosis-dependent vouchers can improve rational use of ACTs
July 21, 2018 - Sweetness depends on molecular interactions between specific sugars and water in saliva
July 21, 2018 - Muscle fitness is strongly associated with improved rate of ageing in the brain
July 21, 2018 - Resetting E-Prescriptions for Opioids Helps Curb Use: Study
July 21, 2018 - Overuse of antibiotics not what the doctor ordered
July 21, 2018 - Bundled-payment system did not lower costs for serious medical conditions, shows study
July 21, 2018 - Therapy dogs found to be effective in reducing ADHD symptoms in children
July 21, 2018 - Could rotating multiple therapists better treat PTSD patients?
July 21, 2018 - Binge drinking impairs working memory in adolescent brain
July 21, 2018 - Dying at home could be beneficial for terminally ill cancer patients and their relatives
July 21, 2018 - Researchers identify subtypes of retinal ganglion cells using single-cell RNA sequencing
July 21, 2018 - Study uncovers opportunities to reduce death by suicide among cancer patients
July 21, 2018 - Genetic sequencing reveals new clues to aggressiveness of prostate cancer
July 21, 2018 - BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
July 21, 2018 - First major study comparing robotic to open surgery published in The Lancet
July 21, 2018 - ADHD medications may fail to improve cognition in healthy college students, study shows
July 21, 2018 - Intervention program that includes a personalized app could benefit teens with suicidal thoughts
July 21, 2018 - Researchers identify new compound that protects against neurodegeneration
July 21, 2018 - Gene therapy may hold potential to treat people with spinal cord injuries
July 21, 2018 - FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
July 21, 2018 - Surgeons have substantial impact on genetic testing in breast cancer patients who need it
July 21, 2018 - Species diversity can have positive and negative impacts on disease transmission
July 21, 2018 - Genome research suggests presence of enteric fever in medieval Europe
July 21, 2018 - Risk of Sensory Deficits Drops With Rising Gestational Age
July 21, 2018 - Mum’s sleep matters—the effect of sleep on an unborn baby
July 21, 2018 - UC San Diego researchers awarded two grants for investigating stem cell-based therapies
July 21, 2018 - Cellular ‘garbage disposal’ may actually work on some of the proteins to neuronal development
July 21, 2018 - More Pregnant Women Having Heart Attacks
July 21, 2018 - Acne Breakouts | NIH News in Health
July 21, 2018 - Change health messaging to focus on potential impact to help stop the next pandemic
July 21, 2018 - Frailty associated with poor survival rates in young heart patients
July 21, 2018 - New discovery could save millions of lives from fatal fungal infections
July 21, 2018 - OBD presents latest data on the use of EpiSwitch™ in predicting patient response to immunotherapy and identifying lymphoma subtypes
July 21, 2018 - Childhood adversity increases susceptibility to addiction via immune response
July 21, 2018 - Scientists identify potential target for the treatment of binge eating
July 21, 2018 - Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer’s
July 21, 2018 - Digital media use raising risk of ADHD symptoms among the young
July 21, 2018 - Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints
July 21, 2018 - Restoring mitochondrial function to reverse aging-related skin wrinkles, hair loss in mice
July 21, 2018 - SP PennTech introduces RW-500 rotary vial washer for biotech, pharmaceutical applications
July 21, 2018 - Researchers to study molecular mechanisms behind susceptibility of males to autism
July 21, 2018 - Using tendon transfer surgery to restore key functions in spinal cord injury patient
July 21, 2018 - Scientists create wearable device that measures cortisol in sweat
July 21, 2018 - Researchers study efficacy and safety of new treatment for OUD
July 21, 2018 - Fourth Published Clinical Trial Confirms Long-Term Safety of Niagen Supplementation at High Doses and Shows Potential for Improvement in Liver Health
July 21, 2018 - Study examines effects of a two-day intermittent calorie restriction diet for patients with type 2 diabetes
July 21, 2018 - Greening vacant urban land reduces feelings of depression for surrounding residents
July 21, 2018 - Parents say intense gun violence in PG-13 movies appropriate for teens 15 and older
July 21, 2018 - Collaborative study to assess effects of exercise training for cognitive deficits in MS
July 21, 2018 - FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system
July 21, 2018 - Protective qualities of ‘good cholesterol’ reduce after menopause
July 21, 2018 - Researchers develop new way to uncover hidden breast cancer tumors
July 21, 2018 - FDA approves first drug for treatment of adult AML patients with specific genetic mutation
July 21, 2018 - Top AI companies join hands to discover novel drugs for DMD
July 21, 2018 - Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications
July 20, 2018 - Researchers design proteins that can self-assemble into complex structures
July 20, 2018 - AVITA Medical expands management team to support launch of RECELL device to treat burns
July 20, 2018 - FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
July 20, 2018 - Developmental screening and surveillance rates remain low, new study suggests
July 20, 2018 - TGen opens tissue donation portal to advance DIPG research
July 20, 2018 - Health impact of highly processed summertime staples
New scientific yardstick released to help early detection of Alzheimer’s disease

New scientific yardstick released to help early detection of Alzheimer’s disease

image_pdfDownload PDFimage_print

The European Commission’s Joint Research Centre (JRC) released a new scientific yardstick, in the form of a certified reference material, to help early detection of Alzheimer’s disease.

The certified reference material will serve to calibrate diagnostic tools for amyloid-β 1-42,  a biomarker for Alzheimer’s disease found in cerebrospinal fluid.

Reliable measurements support earlier and more accurate diagnosis and may facilitate the development of new drugs for treatment.

Tibor Navracsics, Commissioner for Education, Culture, Youth and Sport, responsible for the Joint Research Centre which developed the certified reference material in close collaboration with the International Federation of Clinical Chemistry and Laboratory Medicine and with support of the Alzheimer’s Association, said: “By putting this new instrument at the disposal of researchers and industry, we are making an important step to contain Alzheimer’s disease one day, which destroys irreversibly the memory of affected people, and greatly diminishes their quality of life”.

Vytenis Andriukaitis, Commissioner for Health and Food Safety, said: “Alzheimer’s disease, the most common form of dementia, remains largely underdiagnosed. While certain gene variants increase the risk for Alzheimer’s disease, not all people having the gene will develop the disease. Therefore, reliable markers are necessary not only for early diagnosis but also for drug development and monitoring treatments.”

A reference material to support reliable testing
It is important that research focusses on the very early stages of Alzheimer’s disease. Clinical results have shown that a combination of biomarkers amyloid-β 1-42, tau and phospho-tau have a promising potential to be used in early diagnosis.

The levels of these markers in the cerebrospinal fluid begin to change up to 10 years before the first symptoms of the disease occur.

Diagnostics companies have been developing methods for the measurement of these markers in clinical laboratories.

The JRC worked with a consortium of scientists, supported by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the Alzheimer’s Association, to develop reference systems, including validated reference methods.

To complete the reference systems, reference materials are needed for quality control and for calibration of the routine methods.

This goal has now been achieved for the biomarker amyloid-β 1-42 through the development of a set of certified reference materials ERM-DA480/IFCC, ERM-DA481/IFCC and ERM-DA482/IFCC, which can be obtained through the JRC catalog.  

The availability of reliable markers is crucial not only for early diagnosis but also for the development of medication and monitoring of the effect of treatment in the patients. At present some drug candidates are in the late stage clinical trials.

Dementia and Alzheimer’s disease
Dementia is affecting large numbers of people and is a major burden for society. Alzheimer’s disease is the most common type of dementia affecting 50 – 70 % of all patients. The causes of Alzheimer’s are linked to abnormal clumps (amyloid plaques) and tangled bundles of fibers (consisting of the protein tau) in the brain.

The cost of illness in Europe in 2008 for Alzheimer´s disease and other dementias was estimated to be EUR 167.5 billion. There is also a significant impact on those caring for family members with Alzheimer’s or other dementias which may cause emotional stress and depression.

EU support to Alzheimer’s disease research and collaboration
The EU has been supporting brain research for many years through the Framework Programmes for Research and Innovation, reaching some €500 million a year for basic as well as translational research. Over the past 10 years, over 3300 projects have been funded with a total of €5.3 billion from Horizon 2020, the current EU research and innovation programme, and from its predecessor.

Specifically for Alzheimer’s disease, €544 million were awarded to 370 projects. This sustained investment addresses all aspects of brain research, from better understanding of brain function and dysfunction and the development of methods for diagnosis and monitoring, to prevention, treatment, care and support.

This holistic approach is needed to address the huge challenge of Alzheimer’s disease for which there is no disease-modifying treatment to date.

In the area of public health, EU Member States, Norway and associated partners, such as non-governmental patient organization Alzheimer Europe, cooperate through a joint action funded by the EU Health programme.

The second Joint Action, “Act on Dementia”, is currently organizing collaboration between Member States on four themes: diagnosis and post-diagnostic services, crisis and care coordination, quality of care in residential care and dementia-friendly communities.

Source:

https://ec.europa.eu/jrc/en/news/new-scientific-yardstick-help-early-diagnosis-alzheimers-disease

Tagged with:

About author

Related Articles